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ABSTRACT 
A simple, selective, linear, precise, and accurate RP-HPLC method was developed and validated for the simultaneous estimation of 
Gabapentin & Methylcobalamin from bulk and formulation. Chromatographic separation was achieved Isocratically on an Inertsil C18 
column (150x4.6, 5µ particle size) using a mobile phase Buffer: Acetonitrile in the ratio of 60:40 v/v. The flow rate was 1.0 ml/min, effluents 
were detected at 264 nm and 10µl of sample was injected. Retention time of Gabapentin & Methylcobalamin was found to be 2.7 and 4.13 
min respectively. Linearity of the method was in the concentration range of 25-150 µg for Gabapentin & 0.125-0.750 µg for 
Methylcobalamin. Percent recoveries obtained for both the drugs were 100.00%. The percentage RSD for precision of the method was found 
to be less than 2%. The method was validated according to the ICH guidelines. The method developed was successfully applied for the 
analysis of simultaneous estimation of Gabapentin & Methylcobalamin tablets and was fairly good in comparison with other methods. 
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INTRODUCTION 
Gabapentin is (Figure 1) is 1-(amino methyl) cyclo hexane 
acetic acid. It is an anticonvulsant drug for neuropathic 
pain and adjunct for seizures. It can be used in generalized 
anxiety disorders. Methylcobalamin (Figure 2) is α-(5, 6 
dimethyl benzimidazol) cobalmid cyanide (3+).   It is a 
form of Vit-B12.It is a water soluble vitamin with a key role 
in the normal functioning of brain, and nervous system. It 
has been shown to protect those who take it from 
neurological conditions and ageing in a way that it makes 
different from other drugs or therapy1-4. 
 
        
Figure 1: Gabapentin                                 Figure 2: Methylcobalamin 
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Literature survey revealed HPTLC, UV HPLC methods for 
the estimation of Gabapentin and Methylcobalamin. The 
present study aims to develop simple, accurate, precise 
and selective RP-HPLC assay procedure for the analysis of 
Gabapentin and Methylcobalamin in bulk drug samples and 
in combined dosage. The method is optimized and 
validated as per the International conference on 
Harmonization (ICH) guidelines. 
MATERIALS AND METHODS5-11 
Gabapentin (GABA), Methylcobalamine (MECO) and 
Chemicals were obtained as a sample from Bio-Leo 
Analytical Labs private Ltd with the percentage purity of 
99.1% and 99.7%, respectively. A commercial tablet 
formulation Gabantin Plus® from Sun Parma (Mumbai, 
Maharastra, India) containing 100 mg of GABA and 500µg 
of MECO was purchased from local market and used within 
their shelf life period. HPLC grade acetonitrile was 
obtained from Merck Limited. Analytical grade Buffer 
obtained from SD Fine (Mumbai, India). HPLC grade water 
was obtained by distilling deionizer water produced by a 
Milli-Q Millipore water system (Milford, MA, USA). All 
other chemicals used were of pharmaceutical or analytical 
grade. 
Preparation of mobile phase: 
Mixture of Buffer and Acetonitrile (60:40 ratios) was 
sonicated and the resulting solution was degassed by 
vacuum filtration through 0.4 micron membrane filter. 
Preparation of standard stock solutions: 
Gabapentin working standard 100 mg was weighed and 
transferred along with 0.5 of mg of Methylcobalamine 
working standard into 100 ml volumetric flask, diluent was 
added for making up volume. The resultant solution was 
sonicated. 
Standard preparation: 
One ml of standard stock solution was transferred into 10 
ml volumetric flask and diluted to volume with diluent. 
Preparation of sample solution: 
Pre weighed 20 Tablets were finely triturated.  Finely 
grinded sample quantitatively equivalent to 100 mg of 
Gabapentin and 0.5 mg of Methylcobalamine was 
transferred into 10 ml volumetric flask; 25 ml of diluents 
was added. The resultant was sonicated for 10 minutes and 
diluted to volume with diluent. Further the solution was 
filtered through filter paper. Ten ml of filtrate was diluted   
to 100 ml with mobile phase. 
Method development: 
After various trials, the following chromatographic 
conditions were finally optimized for the simultaneous 
estimation of Gabapentin & Methylcobalamine in a tablet 
dosage form. Mobile phase constitutes of Buffer: 
Acetonirile in the ratio of 60:40 v/v. Detection wave length 
264 nm flow rate 1.0 ml/min, after a steady baseline the 
standard solution were injected and chromatograms were 
recorded until the reproducibility of the peak areas were 
found and finally 100 μg/ml of the standard solution of the 
individual samples of Gabapentin and Methylcobalamine 
and mixed standard solutions were injected and the 
chromatograms were recorded. The separation of 
Gabapentin and Methylcobalamine was observed with 
retention times of 2.7 and 4.13 min respectively. The 
typical chromatograms of the standard solutions were 
recorded for the repeatability and the respective 
chromatogram was given in Figure 3. 
 
 
Figure 3: Typical chromatogram of Gabapentin and Methylcobalamine detection at 264nm. 
Method validation: 
The proposed method was validated as per ICH guidelines. 
System suitability data for Gabapentin and Methylcobalamin 
SR .No Peak Name Retention 
Time 
Area Plate 
Count 
USP 
Tailing 
1 Gabapentin 2.274 1173835 3345 1.15 
2 Methylcobalamin 4.132 136983 6228 1.11 
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Precision: 
The precision of the method verified by repeatability and 
by intermediate precision. Repeatability was checked by 
injecting six individual preparations of Gabapentin and 
Methylcobalamin real sample (tablets). The intermediate 
precision of the method was also evaluated using different 
analyst and performing the analysis on different days. 
Precision of assay method was evaluated by carrying out 
six independent assays of real sample of Gabapentin and 
Methylcobalamin at 100 μg/ml level against qualified 
reference standard. The intermediate precision of the 
assay method was evaluated by different analysts by 
making use of different columns and different lot of the 
sample.
 
Table 1: System Precision Study Results: 
Name Gabapentin Methylcobalamin 
Injection-1 1179101 136890 
Injection -2 1173310 136556 
Injection -3 1176860 136884 
Injection -4 1177331 136415 
Injection -5 1182173 136967 
Injection -6 1188341 135452 
Mean 1179519 136527 
Standard deviation 5204.9 569.53 
% RSD 0.441 0.42 
 
Table 2: Method Precision Study Results: 
Name Gabapentin Methylcobalamin 
Injection-1 1187345 136875 
Injection -2 1180165 138974 
Injection -3 1189456 136888 
Injection -4 1178144 138565 
Injection -5 1178345 137145 
Injection -6 1181122 138788 
Mean 1182430 137873 
Standard deviation 4804.6 1002.45 
% RSD 0.406 0.73 
 
Linearity: 
The linearity range was found to be from 25 µg to 150 µg for Gabapentin and 0.125 µg to 0.75 µg for Methylcobalamin. 
 
Figure 4: Linearity of Gabapentin 
 
Figure 5: Linearity of Mecobalamine
 
Accuracy: 
Accuracy of the assay method was evaluated in triplicate 
using three concentration levels 80, 100 and 120μg/ml on 
real sample (tablets). Standard addition and recovery 
experiments were conducted on real sample to determine 
accuracy the method. Study was carried out in triplicate 
using three (80, 100 and 120%) concentration levels. The 
percentages of recoveries for Gabapentin and 
Methylcobalamin were calculated. 
 
Table 3: Accuracy data for Gabapentin: 
% Concentration 
(at specification 
level) 
Area Amount Added  
(mg) 
Amount found  
(mg) 
% 
Recovery 
Mean 
Recovery 
80% 924479 80.00 78.76 98.45 
99.09 100% 1168610 100.00 99.55 99.55 
120% 1398264 120.00 119.12 99.27 
R² = 0.9999 
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Table 4: Accuracy data for Methylcobalamin: 
% Concentration (at 
specification level) 
Area Amount Added  
(mg) 
Amount found  
(mg) 
% 
Recovery 
Mean 
Recovery 
80% 110498 0.40 0.40 100.83  
99.93 100% 136596 0.50 0.50 99.72 
120% 163137 0.60 0.60 99.24 
 
Table.5: LOD of Gabapentin and Methylcobalamin: 
Parameters Gabapentin Methylcobalamin 
Slope 19494 10926 
Intercept (C) 4627 487.5 
LOD (µg/ml) 0.78 0.15 
 
Table 6: LOQ of Gabapentin and Methylcobalamin: 
Parameters Gabapentin Methylcobalamin 
Slope 194943 10926 
Intercept (C) 4627 487.5 
LOQ (µg/ml) 2.73 0.45 
 
Robustness: 
To determine the robustness of the developed method, 
experimental conditions were deliberately altered and the 
system suitability parameters were evaluated. Tailing 
factor for Gabapentin and Methylcobalamin was recorded. 
The flow rate of the mobile phase was 1.0 ml/min, to study 
the effect of flow rate on the retention time; flow was 
changed by ± 0.2 units from 0.8 to 1.2 ml/min. The effect of 
the column temperature on retention time was studied at 
30 ºC. 
 
Table 7: Robustness data for Gabapentin and Methylcobalamin: 
Parameter Gabapentin Methylcobalamin 
 Retention Time  Theoretical Plate no  Retention Time  Theoretical Plate no  
Flow rate- 0.8 ml 2.00 3043043 3.363 2137383 
Flow rate- 1.2 ml  2.368 2413944 4.813 1688920 
Temperature - 25°C 2.261 2755918 4.157 1932082 
Temperature- 35°C 2.273 2970931 4.323 1945900 
 
Table 8: Comparison table: 
CROMATOGRAPHIC CONDITIONS 
 Method Developed REF 10 REF 11 
HPLC system WATERS  E 2695 WATERS 515 pump WATERS  E 2695 
Detector PDA PDA PDA 
Column 
C 18 
 (150x4.6mmx 5µm) 
C 18 
C 18  
(250x4.6mmx 5µm) 
Temperature 30◦C Room Temp. 30◦C 
Elution Isocratic Isocratic Isocratic 
Mobile Phase 
Buffer:CAN 
(60:40) 
0.1% OPA:ACN 
(55:45v/v) 
OPA :MEOH 
(50:50v/v) 
Flow Rate 1ml/min 1ml/min 0.8ml/min 
Injection volume 10µl 10µl 10µl 
Wavelength 264nm 271nm 275nm 
Run time 8 min 5 min 6 min 
SYSEM SUTABILITY PARAMETERS 
 Method Developed REF 10 REF 11 
 GABA MCOB GABA MCOB GABA MCOB 
RT(min) 2.7 4.13 2.5 3.08 2.896 4.459 
LOD (µg/ml) 0.78 0.15 0.984 0.0068 2.83 2.44 
LOQ  (µg/ml) 2.73 0.45 3.28 0.0226 9.46 8.16 
Linearity (µg/ml) 25 -150 0.125 - 0.750 600 -1800 1 - 3 50 - 150 50 – 150 
Accuracy (%) 99.00 -99.55 99.24 -100.83 99.98 -100.28 
99.65 -
100.38 
100.0 -
100.0 
100.0 - 
100.0 
Precision (%RSD) 0.15 0.21 0.13 0.13 0.34 0.13 
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CONCLUSION 
The present results provide clear evidence that the 
proposed method can be successfully used for 
simultaneous determination of drug content in marketed 
formulations. 
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